Suppr超能文献

[抗高血压药物服用情况评估:如何评估、在何处评估以及何时评估?]

[Assessment for antihypertensive drug intake: How, where and when?].

作者信息

Bouhanick Béatrice, Fonquernie Pauline, Bedue India, Schavgoulidze Anaïs, Gandia Peggy

机构信息

Service d'HTA et de thérapeutique, pôle cardiovasculaire et métabolique, CHU Rangueil, 31000 Toulouse, France; UMR 1027, université Toulouse 3, 31000 Toulouse, France.

Laboratoire de pharmacocinétique et toxicologie, institut fédératif de biologie, CHU Purpan, 330, avenue de Grande-Bretagne, TSA 40031, 31059 Toulouse cedex 09, France.

出版信息

Therapie. 2019 Dec;74(6):651-664. doi: 10.1016/j.therap.2019.05.002. Epub 2019 May 28.

Abstract

AIM

Hypertension is a public health problem managed according to therapeutic strategies published in France by the Hauteautoritéde santé (HAS - French Health Authorities). For patients with resistant hypertension, related or not to a non-adherence, prescribers need to be sure the exposure is high enough to achieve the tensional target. Quantitative analysis of antihypertensive drugs in different biological matrices (blood/urine) is one possible solution. However, this involves determining the concentrations observed at standard doses and knowing how to interpret the measured concentrations. It is also necessary to identify medical laboratories that can assay antihypertensive drugs. This was the aim of our work.

METHODS

The main antihypertensive drugs recommended by the HAS have been listed. For each of them, we looked for published steady-state plasma/serum concentrations and quantities excreted in the urine at usual dosages. In addition, the elimination half-life and linear pharmacokinetic profile were specified for each antihypertensive agent measured in plasma/serum. Pharmacology-Toxicology laboratories in France likely to carry out assays were identified. The time taken to report the result and the cost of the analysis were also specified.

RESULTS

All of the afore-mentioned information has been collected and presented in a table. This can then be used to compare the plasma/serum concentration or the quantity measured in a patient's urine with the values reported in the literature. In cases where the blood sampling times differ between those of the patient and the published data, the patient's measured value is compared to the estimated value based on the published concentrations and pharmacokinetics.

CONCLUSION

Interpretation of the plasma/serum/urinary value measured or estimated for an antihypertensive drug is a particularly interesting approach to determine if drug exposure is enough and a possible non-adherence. However, this activity is mostly carried out in hospital centres.

摘要

目的

高血压是一个公共卫生问题,需依据法国卫生高级管理局(HAS - 法国卫生当局)发布的治疗策略进行管理。对于顽固性高血压患者,无论是否与治疗依从性相关,开处方者都需要确保药物暴露量足够高,以实现血压目标。对不同生物基质(血液/尿液)中的抗高血压药物进行定量分析是一种可行的解决方案。然而,这需要确定标准剂量下观察到的浓度,并知道如何解读所测浓度。还必须识别能够检测抗高血压药物的医学实验室。这就是我们这项工作的目的。

方法

列出了HAS推荐的主要抗高血压药物。对于每种药物,我们查找了已发表的常规剂量下的稳态血浆/血清浓度以及尿中排泄量。此外,还明确了在血浆/血清中测得的每种抗高血压药物的消除半衰期和线性药代动力学特征。确定了法国可能进行检测的药理 - 毒理学实验室。还明确了报告结果所需的时间以及分析成本。

结果

上述所有信息均已收集并整理成表格形式。然后可用于将患者尿液中测得的血浆/血清浓度或量与文献报道的值进行比较。如果患者的采血时间与已发表数据不同,则将患者的测量值与基于已发表浓度和药代动力学估算的值进行比较。

结论

解读所测或估算的抗高血压药物的血浆/血清/尿液值,是确定药物暴露量是否足够以及是否存在可能的治疗不依从性的一种特别有趣的方法。然而,这项工作大多在医院中心开展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验